Fortified cereals can provide the full daily recommended intake in a single serving
General information/press room, American Thyroid Association (2025) Assessment of thyroid carcinogenic risk and safety profile of GLP1-RA semaglutide (Ozempic) therapy for diabetes mellitus and obesity: A systematic literature review, International Journal of Molecular Sciences (2024) Diabetes mellitus and thyroid cancers: risky correlation, underlying mechanisms and clinical prevention, Diabetes, Metabolic Syndrome, and Obesity (2024) Hyperthyroidism, Cleveland Clinic (2024) Hyperthyroidism, MedLinePlus (2024) Hypothyroidism, Cleveland Clinic (2024) Implications of GLP-1 receptor agonist on thyroid function: A literature review of its effects on thyroid volume, risk of cancer, functionality and TSH levels, Biomolecules (2024) Safety of semaglutide, Frontiers in Endocrinology (2021) Semaglutide injection, MedLinePlus (2025) Semaglutide reprograms macrophages via the GLP-1R/PPARG/ACSL1 pathway to suppress papillary thyroid carcinoma growth, The Journal of Clinical Endocrinology and Metabolism (2025) Suppressed thyroid stimulating hormone levels after initiation of a subcutaneous glucagon-like peptide-1 receptor agonist in a post-thyroidectomy patient managed with levothyroxine case report, Journal of the American Pharmacists Association (2024) Use of GLP-1 receptor agonists and occurrence of thyroid disorders: A meta-analysis of randomized controlled trials, Frontiers in Endocrinology (2022) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Congress could change this in the future, and some organizations are working to get it passed
Funding This work was supported by Scientific Research Fund of Binzhou Medical University (BY2021KYQD032)
Doctors adjust dosing all the time based on individual patient needs
Advertisement We didn't think it was going to be impacting the business as much at the level we think today it is, DXL CEO Harvey Kanter said in a call with analysts in March
